István Láng

The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab

E. Hitre, B. Budai, Tünde Nagy, 2012, Angiogenesis.

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.

Z. Szentirmay, E. Hitre, I. Láng, 2013, European journal of cancer.